FDA, RSNA plan joint 3D printing workshop

The U.S. Food and Drug Administration's (FDA) Centers for Devices and Radiological Health and the RSNA's 3D printing Special Interest Group will be holding a joint meeting on August 31 at the FDA's White Oak Campus in Silver Spring, MD.

The meeting will focus on identifying the current best practices for 3D printing, the level of benefit versus risk for different intended uses of the technology, and gaps in clinical evidence needed to perform effective regulatory review of 3D-printed patient-specific anatomic models, according to the FDA.

The goals for the workshop are to provide a forum for open discussion among experts from the clinical, industry, hospital, and regulatory fields and also to map out priorities for developing scientific evidence, identifying critical quality attributes, and building best practices for the safe clinical use of these 3D-printed models, according to the FDA.

More information on the meeting can be found on the FDA's website.

Page 1 of 383
Next Page